These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25690560)

  • 21. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
    Hagymási K; Reismann P; Rácz K; Tulassay Z
    Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
    Lim S; Oh TJ; Koh KK
    Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclinical hypothyroidism, lipid metabolism and cardiovascular disease.
    Delitala AP; Fanciulli G; Maioli M; Delitala G
    Eur J Intern Med; 2017 Mar; 38():17-24. PubMed ID: 28040402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of thyroid-stimulating hormone with metabolic syndrome in a sample of euthyroid Pakistani population.
    Saleem MS; Shirwany TA; Khan KA
    J Ayub Med Coll Abbottabad; 2011; 23(2):63-8. PubMed ID: 24800345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the relationship between subclinical hypothyroidism and metabolic syndrome components among workers.
    Cheserek MJ; Wu G; Shen L; Shi Y; Le G
    Int J Occup Med Environ Health; 2014 Apr; 27(2):175-87. PubMed ID: 24619737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of thyroid function with obesity and type 2 diabetes in euthyroid Tunisian subjects.
    Kouidhi S; Berhouma R; Ammar M; Rouissi K; Jarboui S; Clerget-Froidevaux MS; Seugnet I; Abid H; Bchir F; Demeneix B; Guissouma H; Elgaaied AB
    Endocr Res; 2013; 38(1):15-23. PubMed ID: 22746188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome.
    Pacifico L; Giansanti S; Gallozzi A; Chiesa C
    Mini Rev Med Chem; 2014; 14(10):791-804. PubMed ID: 25307311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis.
    Guo Z; Li M; Han B; Qi X
    Dig Liver Dis; 2018 Nov; 50(11):1153-1162. PubMed ID: 30224316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid function in critically ill patients.
    Fliers E; Bianco AC; Langouche L; Boelen A
    Lancet Diabetes Endocrinol; 2015 Oct; 3(10):816-25. PubMed ID: 26071885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thyroid disorders and dyslipidemias].
    Deschampheleire M; Luyckx FH; Scheen AJ
    Rev Med Liege; 1999 Sep; 54(9):746-50. PubMed ID: 10589270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?
    Targher G; Chonchol M; Zoppini G; Abaterusso C; Bonora E
    J Hepatol; 2011 May; 54(5):1020-9. PubMed ID: 21145850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different effects of fenofibrate on metabolic and cardiovascular risk factors in mixed dyslipidemic women with normal thyroid function and subclinical hypothyroidism.
    Krysiak R; Gilowski W; Szkrobka W; Okopien B
    Cardiovasc Ther; 2014 Dec; 32(6):264-9. PubMed ID: 25290818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid function status and plasma lipids among cardiology patients in Georgia.
    Chapidze G; Enquobahrie D; Kapanadze S; Dolidze N; Soh J; Williams M
    Georgian Med News; 2007; (148-149):20-5. PubMed ID: 17921537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome.
    Carbone F; Montecucco F; Mach F; Pontremoli R; Viazzi F
    Thromb Haemost; 2013 Nov; 110(5):940-58. PubMed ID: 23966104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease.
    Tahara K; Akahane T; Namisaki T; Moriya K; Kawaratani H; Kaji K; Takaya H; Sawada Y; Shimozato N; Sato S; Saikawa S; Nakanishi K; Kubo T; Fujinaga Y; Furukawa M; Kitagawa K; Ozutsumi T; Tsuji Y; Kaya D; Ogawa H; Takagi H; Ishida K; Mitoro A; Yoshiji H
    JGH Open; 2020 Jun; 4(3):400-404. PubMed ID: 32514444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.
    Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK
    Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.
    Kim D; Vazquez-Montesino LM; Escober JA; Fernandes CT; Cholankeril G; Loomba R; Harrison SA; Younossi ZM; Ahmed A
    Am J Gastroenterol; 2020 Sep; 115(9):1496-1504. PubMed ID: 32496342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
    Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
    Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.